Skip to main content
editorial
. 2009 Apr 7;15(13):1548–1553. doi: 10.3748/wjg.15.1548

Table 2.

Characteristics of papers included in the meta-analysis

Study Mean age Sex
IBS subtype Type of TCA Daily dosage Duration of treatment/follow up (wk)
Female Male
Vahedi et al[16], 2008 36 21 29 D-IBS Amitriptyline 10 mg 8
Talley et al[17], 2008 ND 21 13 D-IBS, C-IBS, Alt-IBS Imipramine 2 wk: 25 mg; Thereafter to the end: 50 mg 12
Morgan et al[18], 2005 39 22 0 D-IBS, C-IBS, Alt-IBS Amitriptyline First week: 25 mg; Thereafter to the end: 50 mg 4
Rajagopalan et al[19], 1998 34.8 11 11 ND Amitriptyline First week: 25 mg; 2nd week: 50 mg; Thereafter to the end: 75 mg 12
Vij et al[20], 1991 32.5 14 36 D-IBS, C-IBS, Alt-IBS Doxepin 75 mg 6
Greenbaum et al[21], 1987 45.2 18 11 D-IBS, C-IBS Desipramine First week: 50 mg; 2nd week: 100 mg; Thereafter to the end: 150 mg 6
Tripathi et al[22], 1983 37 ND ND ND Trimipramine 30 mg 5

IBS: Irritable bowel syndrome; D: Diarrhoea predominant; Alt: Alternating; C: Constipation predominant; TCA: Tricyclic antidepressant.